Not applicableUnknownNCT02764606What this trial is testingCANPOS: Predictive Biomarkers of Tumor Progression in Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Hospices Civils de Lyon 250
Early research (Phase 1)Study completedNCT04925284What this trial is testingStudy of XB002 in Subjects With Solid Tumors (JEWEL-101)Who this might be right forNon Small Cell Lung CancerCervical CancerSCCHN+8 more Exelixis 269
Large-scale testing (Phase 3)Active Not RecruitingNCT06031558What this trial is testingPhase III Study of SY-5007, a RET Inhibitor, in Patients With Locally Advanced or Metastatic RET Fusion-positive NSCLCWho this might be right forNon-Small Cell Lung Cancer Shouyao Holdings (Beijing) Co. LTD 120
Testing effectiveness (Phase 2)Study completedNCT02681549What this trial is testingPembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer (NSCLC)Who this might be right forMelanomaNon-small Cell Lung CancerBrain Metastasis Yale University 41
Post-approval studies (Phase 4)Study completedNCT03134456What this trial is testingPembrolizumab for Metastatic NSCLC Patients Expressing PD-L1 Who Have Their Own PDXWho this might be right forMetastatic Non-Small Cell Lung Carcinoma Samsung Medical Center 50
Early research (Phase 1)Study completedNCT02595866What this trial is testingTesting the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and CancerWho this might be right forAIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more National Cancer Institute (NCI) 58
Not applicableStudy completedNCT02619929What this trial is testingInitial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany and AustriaWho this might be right forNon-Small-Cell Lung CancerBreast Cancer Pierre Fabre Pharma GmbH 108
Testing effectiveness (Phase 2)Study completedNCT03090737What this trial is testingSafety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Bristol-Myers Squibb 129
Testing effectiveness (Phase 2)UnknownNCT06590194What this trial is testingPH009-1 in Patients With EGFR Mutation Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)Who this might be right forAdvanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) Suzhou Puhe Pharmaceutical Technology Co., LTD 96
Not applicableLooking for participantsNCT06428422What this trial is testingThe Impact of Probiotic on Survival and Treatment Response in Metastatic Non-small Cell Lung Cancer PatientsWho this might be right forMetastatic Non-small Cell Lung Cancer Necmettin Erbakan University 100
Testing effectiveness (Phase 2)Study completedNCT02230553What this trial is testingLapatinib Plus Trametinib in KRAS Mutant NSCLCWho this might be right forColorectal Cancer The Netherlands Cancer Institute 35
Not applicableLooking for participantsNCT07174388What this trial is testingAn External Control Arm Study in Non-Small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer N-Power Medicine 650
Testing effectiveness (Phase 2)Ended earlyNCT05513703What this trial is testingAssess Disease Activity of Intravenously (IV) Infused Telisotuzumab Vedotin in Adult Participants With Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon Small Cell Lung Cancer AbbVie 9
Not applicableLooking for participantsNCT06349642What this trial is testingImmune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic PlatformWho this might be right forEarly Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma+24 more Mayo Clinic 324
Testing effectiveness (Phase 2)Study completedNCT02336451What this trial is testingA Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients With ALK-positive NSCLC Metastatic to the Brain and/or to LeptomeningesWho this might be right forALK-positive Non-small Cell Lung Cancer Novartis Pharmaceuticals 156
Testing effectiveness (Phase 2)Active Not RecruitingNCT04699188What this trial is testingStudy of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C MutationWho this might be right forKRAS G12C Mutant Solid TumorsCarcinoma, Non-Small-Cell LungCarcinoma, Colorectal+7 more Novartis Pharmaceuticals 344
Early research (Phase 1)Study completedNCT05639751What this trial is testingPRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 MutationWho this might be right forAdvanced Solid TumorMetastatic Solid TumorNon-small Cell Lung Cancers+1 more Prelude Therapeutics Incorporated 135
Testing effectiveness (Phase 2)Ended earlyNCT03325166What this trial is testingPembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain MetastasesWho this might be right forLung Carcinoma Metastatic in the BrainStage IV Lung Non-Small Cell Cancer AJCC v7 OHSU Knight Cancer Institute 2
Testing effectiveness (Phase 2)Ended earlyNCT03382912What this trial is testingStudy of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung CancerWho this might be right forNon Small Cell Lung Cancer Eli Lilly and Company 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT05013450What this trial is testingDupilumab_Metastatic NSCLCWho this might be right forMetastatic Non-small Cell Lung Cancer Thomas Marron 33